AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25457871 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D titanium miniplate
Number of subjects: 20
Study 25457871 — intervention group
Group type: COMPARATOR
Intervention: Standard titanium miniplate
Number of subjects: 20
Study 25457871 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 20
Study 24207163 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary Care Triple P (PCTP)
Number of subjects: 81
Study 24207163 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (UC)
Number of subjects: 81
Study 21315841 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT responders (n = 32)
Number of subjects: 54
Study 21315841 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT nonresponders (n = 19)
Number of subjects: 54
Study 19625315 — intervention group
Group type: EXPERIMENTAL
Intervention: Preimplantation genetic screening (PGS)
Number of subjects: 199
Study 17458427 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma controller medication adherence
Number of subjects: 200
Study 17458427 — intervention group
Group type: COMPARATOR
Intervention: Physician instruction to use controller medication intermittently
Number of subjects: 200
Study 17458427 — intervention group
Group type: EXPERIMENTAL
Intervention: Desire for control over treatment
Number of subjects: 200
Study 17458427 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of information adequacy
Number of subjects: 200
Study 15063247 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletonized internal thoracic artery graft
Number of subjects: 19
Study 15063247 — intervention group
Group type: COMPARATOR
Intervention: Pedicled internal thoracic artery graft
Number of subjects: 19
Study 11411906 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% isotretinoin cream with chemical sunscreens
Number of subjects: 0
Study 11411906 — intervention group
Group type: COMPARATOR
Intervention: 4% benzoyl peroxide cream
Number of subjects: 0
Study 9580420 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in a pharmacological hypolipidaemic trial (12 weeks)
Number of subjects: 106
Study 7978429 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia (TEA) (T1‐5 block)
Number of subjects: 20
Study 7978429 — intervention group
Group type: COMPARATOR
Intervention: Control group (standardized fentanyl-nitrous oxide anesthesia without TEA)
Number of subjects: 20
Study 7978429 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 7978429 — intervention group
Group type: EXPERIMENTAL
Intervention: TEA group
Number of subjects: 20
Study 2657675 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 25 mg
Number of subjects: 164
Study 2657675 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 50 mg
Number of subjects: 164
Study 2657675 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 100 mg
Number of subjects: 164
Study 2657675 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 600 mg
Number of subjects: 164
Study 2657675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study 1211587 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical analgesia using lignocaine applied to the pyriform fossae for superior laryngeal nerve block and topical analgesia of larynx and trachea.
Number of subjects: 0
Study 31760855 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring and telecoaching (TELE) for six months
Number of subjects: 122
Study 31760855 — intervention group
Group type: COMPARATOR
Intervention: Traditional six-month follow-up programme with monthly calls (CON)
Number of subjects: 122
Study 31760855 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring and telecoaching (TELE)
Number of subjects: 122
Study 29673620 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone 2mg
Number of subjects: 50
Study 29673620 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone 4mg
Number of subjects: 50
Study 29673620 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000mg
Number of subjects: 50
Study 29673620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 28177706 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA (0.087 g/kg body mass)
Number of subjects: 16
Study 25117999 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuna fish oil (high in long-chain omega-3 fatty acids)
Number of subjects: 616
Study 25117999 — intervention group
Group type: COMPARATOR
Intervention: Sunola oil (low in omega-3 fatty acids)
Number of subjects: 616
Study 25117999 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma omega-3 fatty acid levels
Number of subjects: 616
Study 23261884 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructions to remove clothing
Number of subjects: 99
Study 23261884 — intervention group
Group type: COMPARATOR
Intervention: No instructions about clothing removal
Number of subjects: 99
Study 21618205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 21618205 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe fibrosis (HRCT)
Number of subjects: 79
Study 21618205 — intervention group
Group type: EXPERIMENTAL
Intervention: No or moderate fibrosis (HRCT)
Number of subjects: 79
Study 21618205 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe fibrosis with disease duration 0-2 years
Number of subjects: 79
Study 18643896 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 Hz rapid-rate lumbosacral magnetic stimulation (rLSMS) for 15 min
Number of subjects: 8
Study 18643896 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 Hz rapid-rate lumbosacral magnetic stimulation (rLSMS) for 15 min
Number of subjects: 8
Study 18643896 — intervention group
Group type: COMPARATOR
Intervention: Sham rapid-rate lumbosacral magnetic stimulation (rLSMS) for 15 min
Number of subjects: 8
Study 16540962 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine group (20 mL of a 10% povidone-iodine aqueous solution rinsing)
Number of subjects: 98
Study 16540962 — intervention group
Group type: COMPARATOR
Intervention: Saline group (60 mL of saline solution rinsing)
Number of subjects: 98
Study 16540962 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard regimen without instillation, aspiration of oropharyngeal secretions)
Number of subjects: 98
Study 12684129 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium and vitamin E supplementation
Number of subjects: 32400
Study 12684129 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 32400
Study 10856105 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose interferon alfa-2b (HDI) for 1 year
Number of subjects: 642
Study 10856105 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose interferon alfa-2b (LDI) for 2 years
Number of subjects: 642
Study 10856105 — intervention group
Group type: COMPARATOR
Intervention: Observation (Obs)
Number of subjects: 642
Study 8647566 — intervention group
Group type: EXPERIMENTAL
Intervention: Crataegus (Hawthorn)
Number of subjects: 0
Study 8647566 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 1345870 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine ultrasonography (screened group)
Number of subjects: 2011
Study 6142252 — intervention group
Group type: EXPERIMENTAL
Intervention: Towne strain cytomegalovirus (CMV) vaccine
Number of subjects: 91
Study 6142252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 31125354 — intervention group
Group type: EXPERIMENTAL
Intervention: RESPOND (telephone-based patient-centred falls prevention program)
Number of subjects: 430
Study 31125354 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 430
Study 29329499 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Seizure Therapy (MST)
Number of subjects: 37
Study 29329499 — intervention group
Group type: COMPARATOR
Intervention: Electroconvulsive Therapy (ECT)
Number of subjects: 37
Study 27704167 — intervention group
Group type: COMPARATOR
Intervention: Single-hormone artificial pancreas
Number of subjects: 17
Study 27704167 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-hormone artificial pancreas
Number of subjects: 17
Study 24853314 — intervention group
Group type: COMPARATOR
Intervention: Wound infiltration (WI) with 1 mg·kg(‐1) 0.25% bupivacaine
Number of subjects: 40
Study 24853314 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided rectus sheath block (USGRSB) with 0.5 mg·kg(‐1) 0.25% bupivacaine per side
Number of subjects: 40
Study 22832531 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified balanced salt solution (BSS Plus)
Number of subjects: 70
Study 22832531 — intervention group
Group type: COMPARATOR
Intervention: Ringer lactate
Number of subjects: 70
Study 20176428 — intervention group
Group type: EXPERIMENTAL
Intervention: Story-based safety messages
Number of subjects: 0
Study 20176428 — intervention group
Group type: COMPARATOR
Intervention: Concrete (non-anecdotal) safety messages
Number of subjects: 0
Study 20176428 — intervention group
Group type: COMPARATOR
Intervention: Traditional abstract safety messages
Number of subjects: 0
Study 17907207 — intervention group
Group type: EXPERIMENTAL
Intervention: ESCAPE-knee pain (Indiv-rehab)
Number of subjects: 0
Study 17907207 — intervention group
Group type: EXPERIMENTAL
Intervention: ESCAPE-knee pain (Grp-rehab)
Number of subjects: 0
Study 17907207 — intervention group
Group type: COMPARATOR
Intervention: Usual primary care
Number of subjects: 0
Study 17907207 — intervention group
Group type: EXPERIMENTAL
Intervention: Indiv-rehab vs Grp-rehab
Number of subjects: 0
Study 17907207 — intervention group
Group type: EXPERIMENTAL
Intervention: ESCAPE-knee pain (Indiv-rehab and Grp-rehab)
Number of subjects: 0
Study 16901887 — intervention group
Group type: EXPERIMENTAL
Intervention: Male condom-focused HIV prevention intervention
Number of subjects: 201
Study 12496325 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 729
Study 9806648 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose chemoradiotherapy with 5-fluorouracil (5-FU) and mitomycin
Number of subjects: 46
Study 9806648 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose chemoradiotherapy with 5-FU and mitomycin
Number of subjects: 46
Study 7659873 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate‐trometamol‐phosphate mixture (250 ml with buffering capacity 500 mmol/l)
Number of subjects: 502
Study 7659873 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (250 ml)
Number of subjects: 502
Study 7659873 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffer therapy (sodium bicarbonate)
Number of subjects: 502
Study 7659873 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 502
Study 2503620 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate arteriographic evaluation (AG)
Number of subjects: 135
Study 2503620 — intervention group
Group type: COMPARATOR
Intervention: Delayed arteriographic evaluation (AG)
Number of subjects: 135
Study 2503620 — intervention group
Group type: EXPERIMENTAL
Intervention: Arteriographic evaluation (AG)
Number of subjects: 135
Study 2503620 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft clinical signs
Number of subjects: 135
Study 1046183 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior modification training in body positioning
Number of subjects: 10
Study 1046183 — intervention group
Group type: COMPARATOR
Intervention: Customary body positioning nursing care
Number of subjects: 10
Study 6118631 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg ergocalciferol (oral and intramuscular administration)
Number of subjects: 0
Study 6118631 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg ergocalciferol (oral administration)
Number of subjects: 0
Study 6118631 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg ergocalciferol (once a year regimen)
Number of subjects: 0
Study 31082847 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsoulnar incision
Number of subjects: 46
Study 31082847 — intervention group
Group type: COMPARATOR
Intervention: Midline incision
Number of subjects: 46
Study 31082847 — intervention group
Group type: COMPARATOR
Intervention: Dorsoulnar incision with immobilization
Number of subjects: 46
Study 31082847 — intervention group
Group type: COMPARATOR
Intervention: Midline incision with early mobilization
Number of subjects: 46
Study 31122178 — intervention group
Group type: EXPERIMENTAL
Intervention: Translational-rotational shifts in 6 degrees of freedom (X, Y, Z, α, β, γ)
Number of subjects: 20
Study 27629405 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised Hip Therapy (PHT)
Number of subjects: 42
Study 27629405 — intervention group
Group type: COMPARATOR
Intervention: Control group (arthroscopic surgery)
Number of subjects: 42
Study 24829210 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep-TMS treatment (20 daily sessions at 20Hz, 120% MT)
Number of subjects: 30
Study 24829210 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 30
Study 22527609 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction
Number of subjects: 102
Study 22527609 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness
Number of subjects: 102
Study 22527609 — intervention group
Group type: COMPARATOR
Intervention: Problem-solving
Number of subjects: 102
Study 22527609 — intervention group
Group type: COMPARATOR
Intervention: Rumination
Number of subjects: 102
Study 22527609 — intervention group
Group type: COMPARATOR
Intervention: Distraction (Study 1)
Number of subjects: 102
Study 19640833 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition 1: 'Guía Para Dejar de Fumar', a static National Cancer Institute evidence‐based stop smoking guide
Number of subjects: 1000
Study 19640833 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition 2: Condition 1 plus E‐mail reminders to return to the site
Number of subjects: 1000
Study 19640833 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition 3: Condition 2 plus mood management lessons
Number of subjects: 1000
Study 19640833 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition 4: Condition 3 plus a 'virtual group' (an asynchronous bulletin board)
Number of subjects: 1000
Study 19640833 — intervention group
Group type: COMPARATOR
Intervention: Control group (missing data assumed to be smoking)
Number of subjects: 1000
Study 17642239 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab with concomitant MTX therapy
Number of subjects: 0
Study 17642239 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 16313283 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 37.5 mg/paracetamol 325 mg
Number of subjects: 24
Study 16313283 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine 30 mg/paracetamol 500 mg
Number of subjects: 24
Study 12407042 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (LNG-IUS)
Number of subjects: 82
Study 12407042 — intervention group
Group type: COMPARATOR
Intervention: Copper intrauterine device (IUD)
Number of subjects: 82
Study 9521260 — intervention group
Group type: EXPERIMENTAL
Intervention: glatiramer acetate (Copaxone)
Number of subjects: 251
Study 9521260 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 251
Study 7855200 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (100 mg)
Number of subjects: 8
Study 7855200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 2563308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfasalazine
Number of subjects: 63
Study 2563308 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 56648 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone stimulation test
Number of subjects: 10
Study 31794027 — intervention group
Group type: EXPERIMENTAL
Intervention: mhGAP-based training (6 weeks, weekly sessions including lectures, discussions, role plays, and support sessions)
Number of subjects: 112
Study 31794027 — intervention group
Group type: EXPERIMENTAL
Intervention: mhGAP-based training (Group 1)
Number of subjects: 112
Study 31794027 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 2, received training after Group 1)
Number of subjects: 112
Study 31187764 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 90
Study 31187764 — intervention group
Group type: COMPARATOR
Intervention: Tramadol
Number of subjects: 90
Study 28347184 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy (TRT)
Number of subjects: 74
Study 28347184 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 74
Study 24708386 — intervention group
Group type: EXPERIMENTAL
Intervention: Group feedback condition (n = 137)
Number of subjects: 263
Study 24708386 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) condition (n = 126)
Number of subjects: 263
Study 23910714 — intervention group
Group type: EXPERIMENTAL
Intervention: Phaco-chop
Number of subjects: 3
Study 23910714 — intervention group
Group type: COMPARATOR
Intervention: Divide-and-conquer
Number of subjects: 3
Study 23910714 — intervention group
Group type: COMPARATOR
Intervention: Stop-and-chop
Number of subjects: 3
Study 21365307 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback technique using RESPeRATE™ device
Number of subjects: 81
Study 21365307 — intervention group
Group type: COMPARATOR
Intervention: Control group (no biofeedback)
Number of subjects: 81
Study 18515454 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) using a gelatin-based protein drink
Number of subjects: 16
Study 18515454 — intervention group
Group type: COMPARATOR
Intervention: Placebo condition (neutral tryptophan levels)
Number of subjects: 16
Study 17566314 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine/benazepril 10/40 mg/day
Number of subjects: 812
Study 17566314 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine/benazepril 10/20 mg/day
Number of subjects: 812
Study 17566314 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 10 mg/day (monotherapy)
Number of subjects: 812
Study 17566314 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine/benazepril 10/40 mg/day and 10/20 mg/day
Number of subjects: 812
Study 17566314 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine/benazepril combinations
Number of subjects: 812
Study 14732240 — intervention group
Group type: EXPERIMENTAL
Intervention: Ammonium sulphate fertiliser ((NH(4))(2)SO(4))
Number of subjects: 4
Study 14732240 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 4
Study 11182396 — intervention group
Group type: EXPERIMENTAL
Intervention: CT scan
Number of subjects: 128
Study 11182396 — intervention group
Group type: COMPARATOR
Intervention: Standard management
Number of subjects: 128
Study 9186989 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term corticosteroid treatment
Number of subjects: 149
Study 1405532 — intervention group
Group type: EXPERIMENTAL
Intervention: Locus equations for children's production of stop + vowel tokens
Number of subjects: 16
Study 1405532 — intervention group
Group type: COMPARATOR
Intervention: Comparison to adult norms
Number of subjects: 16
Study 3895381 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg twice daily)
Number of subjects: 57
Study 3895381 — intervention group
Group type: EXPERIMENTAL
Intervention: Novaluzid (10 ml seven times daily)
Number of subjects: 57
Study 3895381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 31248384 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive restructuring (CR)
Number of subjects: 0
Study 31248384 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural activation (BA)
Number of subjects: 0
Study 31248384 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem solving (PS)
Number of subjects: 0
Study 31248384 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation (RE)
Number of subjects: 0
Study 31248384 — intervention group
Group type: EXPERIMENTAL
Intervention: CR - BA - RE - PS
Number of subjects: 0
Study 31248384 — intervention group
Group type: EXPERIMENTAL
Intervention: BA - CR - RE - PS
Number of subjects: 0
Study 31248384 — intervention group
Group type: EXPERIMENTAL
Intervention: PS - GA - CR - RE
Number of subjects: 0
Study 31248384 — intervention group
Group type: EXPERIMENTAL
Intervention: RE - PS - BA - CR
Number of subjects: 0
Study 27893574 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:1 PRBC/FFP transfusion strategy
Number of subjects: 45
Study 27893574 — intervention group
Group type: COMPARATOR
Intervention: 4:1 PRBC/FFP transfusion strategy
Number of subjects: 45
Study 25516019 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT), 10 sessions
Number of subjects: 0
Study 22961466 — intervention group
Group type: EXPERIMENTAL
Intervention: Potentially Harmful Behaviors (PHB)
Number of subjects: 612
Study 22961466 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemplary Care (EC)
Number of subjects: 612
Study 22961466 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiving Stressors (daily care bother, behavioral bother, burden)
Number of subjects: 612
Study 21457273 — intervention group
Group type: EXPERIMENTAL
Intervention: Masked sad facial expressions during an easy task
Number of subjects: 0
Study 21457273 — intervention group
Group type: EXPERIMENTAL
Intervention: Masked happy facial expressions during a difficult task
Number of subjects: 0
Study 21457273 — intervention group
Group type: COMPARATOR
Intervention: Masked sad facial expressions during a difficult task
Number of subjects: 0
Study 21457273 — intervention group
Group type: COMPARATOR
Intervention: Masked happy facial expressions during an easy task
Number of subjects: 0
Study 18208432 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-bundle technique
Number of subjects: 72
Study 18208432 — intervention group
Group type: COMPARATOR
Intervention: Single intra-articular bundle plus extra-articular sling (Control)
Number of subjects: 72
Study 16565618 — intervention group
Group type: EXPERIMENTAL
Intervention: CAregiver Sleep Intervention (CASI)
Number of subjects: 30
Study 16565618 — intervention group
Group type: COMPARATOR
Intervention: Control caregivers
Number of subjects: 30
Study 14501025 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering treatment (statins)
Number of subjects: 98
Study 10593621 — intervention group
Group type: COMPARATOR
Intervention: Placebo-treated patients with elevated depressive symptoms
Number of subjects: 671